Skip to main content
Year archive

Vivoryon Therapeutics N.V. — 2018 filings

All 28 regulatory filings released by Vivoryon Therapeutics N.V. (VVY) in 2018, sourced directly from the official regulator.

28 Filings
2018 Period
2018 filings (28)
Filing Released Lang
Probiodrug to attend J.P. Morgan Healthcare Conference in January 2019
Report Publication Announcement
2018-12-18 English
Probiodrug AG Reports Third Quarter 2018 Business Update
Earnings Release Q3 2018
2018-11-29 English
Probiodrug Reports Third Quarter 2018 Business Update
Interim / Quarterly Report Q3 2018
2018-11-29 English
Probiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018
Report Publication Announcement
2018-11-22 English
Probiodrug AG: Bekanntmachung der Einberufung zur Hauptversammlung am 07.12.2018 in Halle (Saale) mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2018-10-24 German
Probiodrug publishes SAPHIR data in peer reviewed journal
Regulatory Filings
2018-10-16 English
Probiodrug veroffentlicht Daten der SAPHIR-Studie in einer Peer-Review-Publikation
Legal Proceedings Report
2018-10-16 German
Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act
Legal Proceedings Report
2018-10-15 German
Probiodrug Reports Management Changes
Board/Management Information
2018-10-05 English
Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy
Board/Management Information
2018-09-04 English
Probiodrug ernennt Dr. Michael Schaeffer zum Executive Vice President Business & Strategy
Board/Management Information
2018-09-04 German
Probiodrug Reports Financial Results for H1 2018 and Corporate Update
Interim / Quarterly Report H1 2018
2018-08-30 English
Probiodrug berichtet Finanzergebnisse fur das erste Halbjahr 2018 und Unternehmens-Update
Earnings Release H1 2018
2018-08-30 German
Probiodrug AG to Publish First Half 2018 Results on August 30, 2018
Report Publication Announcement
2018-08-23 English
Report Publication Announcement 2018
Report Publication Announcement
2018-08-23 English
DGAP-DD: Probiodrug AG english
Director's Dealing
2018-07-13 English
DGAP-DD: Probiodrug AG english
Director's Dealing
2018-07-12 English
Ordinary General Meeting of Shareholders of Probiodrug AG
AGM Information
2018-06-22 English
DGAP-DD: Probiodrug AG english
Director's Dealing
2018-05-23 English
Probiodrug AG reports First Quarter 2018 Business Update
Report Publication Announcement Q1 2018
2018-05-15 English
Probiodrug AG: Bekanntmachung der Einberufung zur Hauptversammlung am 21.06.2018 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2018-05-09 German
Probiodrug positioning its pGlu-Abeta Antibody in the field of Abeta antibodies
Regulatory Filings
2018-05-08 English
Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018
Report Publication Announcement
2018-05-08 English
Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer
Board/Management Information
2018-04-24 English
Probiodrug reports full year 2017 financial results
Interim / Quarterly Report FY 2017
2018-04-03 English
Probiodrug AG to Publish its Full Year 2017 Results on 3 April 2018
Report Publication Announcement
2018-03-27 English
Report Publication Announcement 2018
Report Publication Announcement
2018-03-27 English
Probiodrug to present at 255th ACS National Meeting & Exposition
Earnings Release Q1 2018
2018-03-16 English